Obstetrics Flashcards

1
Q

Risk factors for recurrent APH

A
HTN/PET
Substances
Antiphospholipid
IUGR
Short inter pregnancy interval
Abdominal trauma
Polyhydramnios
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Risk factors placenta praevia

A

Maternal
- AMA
Ethnicity - Asian
Smoking

Obstetric
IVF
Previous praevia
Previous cs
Multiple
Short inter pregnancy interval
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Fetal fibronectin

A

Glycoprotein in amniotic fluid, placental tissue, and extracellular substance of decidua basalis.
Release through mechanical or inflammatory mediated damage to membranes or placenta before birth

PPV for birth <34 weeks approx 20%, quantitative may have mor value.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Cases preterm birth

A

IATROGENIC (40%)

PPROM (60%)
Cervix - (ERPOC, multiple LLETZ, fully cs)
Infection - MSU, chlamydia, BV
SES - smoking
Multiple
Endocrine
Haemorrhage
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Consequence PTB

A
  • Visual problems related to retinopathy of prematurity
  • Sensorineural hearing loss
  • Impaired gross and fine motor skills due to cerebral palsy
  • Delayed speech and language acquisition
  • Impaired concentration, increased rates of attention deficit disorder
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Components safer baby bundle

A
Smoking cessation
Side sleeping
Fetal growth restriction
Decreases fetal movements
Timing of birth
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Mirror syndrome and differences from PET

A

Generalised maternal oedema, often with pulmonary involvement, hydroponic placenta producing sFLT1

Anytime during antenatal or postpartum, rapid weight gain, increasing peripheral oedema, progressive SOB,

Contrast;
HCT usually LOW (haemodilut)
Amniotic fluid HIGH (rather than low)
Fetus always shows signs of hydrops

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Brest milk production.

A

Alveoli - lacterious ducts, lacteriferous sinus, milk duct, ejection via nipple

AN: prolactin and placental lactogen producing milk, suppressed by estrogen and progesterone, once placenta delivered, sudden drop E+P allowing prolactin to stimulate milk production, oxytocin via nipple stimulation causes contraction of myoepithelial cells, milk expelled via lactiferous ducts—->sinus—> milk duct, nipple

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Subgaleal haemorrhage

A

Subaponeurotic. Bleeding into space between epidural aponeurosis and periosteum, caused by rupture emissary veins (btwn dural sinuses and scalp veins).
LARGE space, tehrefore high mord and mort.

Can contain 250mL of blood with only 1cm increase scalp thickness. Mort 12-25%.

Apgar <7 without sign asphyxia, particularly if prolongd vacuum.
Later-haemodynamic instability, tachycardia/tachypnoea, poor activiy, pallor, anaemia, coagulopathy, hypotension, acidosis, death.

Localised - scalp swelling + laxity “older leather pouch” filled w fluid, pitting oedema over had/in front of ears, gravity dependent, displacement ear lobes, perieauricular oedema.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Caput succedaneum

A

Serosanguinous, extra-aponeurotic collection may extended over midline and suture lines.
Vacuum = prominnent articial caput at site of chignon, but chignon reduces within AN HOUR of birth, not assoc w NN haem.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Cephalohaematoma

A

Friction during birth gives bleeding between periosteum and underlying SKULL, can happy any time, more likely w instrumental. Soft, fluctuant, swelling, well defined. May increase over 12-24 hours, may take WEEKS to resolve.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Pathophys AFE

A

Fetal debris + amniotic fluid breaches maternal circulation, causes anaphylactoid reaction and peripheral vasodilation and reduced venous return/hypotension, triggers extrinsic coagulation cascade and get consumptive coagulopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Tocolytic agents

A

Terbutaline 250mcg sc or IV
Salbutamol 100mcg IV
GTN 400mcg sublingual

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Factors that control FHR variability on CTG

A

Blood pressure/volume - baroreceptors
Oxygenation - chemoreceptors
Parasympathetic nervous - ACh from vagal nerve on SA node
SNS - adr/norad on myocardium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

FIGO criteria for HIE/CP in term infants

A

Metabolic acidosis (pH <7.0, Base deficit >12, lactate >10)

Low apgars at 1 and 5 minutes

Early onset HIE

Early imaging studies showing acute and non-focal cerebral anomaly

Spastic quadriplegic or dyskinetic cerebral palsy

Exclusion of other etiologies such as birth trauma, COAg, infection, generic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Pathophysiology of RDS

A

Surfactant deficiency associated with prematurity

Surfactant reduces surface tension and allows aeration at end expiration. Without surfactant reduced aeration of lungs at end expiration, collapsed alveoli, reduced compliance, and mismatched ventilation and perfusion. Reduced surfactant also can cause irritation and inflammation, epithelial injury thus exacerbating the mismatch. This can result in hypoxia which manifests as tachypnoea, nasal flaring, indrawing, grunting, hypoxia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Strategies to prevent post CS endometritis

A

Pre-op antibiotic prophylaxis: 1st Gen cephalosporin within 30-60 mins knife to skin, RR0.5, CSOAP trial showed reduction with additional antibiotic of azithromycin

Appropriate skin prep - alcohol based

Pre op vagina cleansing: 30s with iodine containing solution RR 0.5 for endometritis, fever, wound infection

avoidance MROP

Closure of sc fat if >2cm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

How to reduce cs rate (NIcE guideline)

A
Avoidance undiagnosed breech
IOL from 41/40 for low risk women
Use of partogram with 4 hour action line
FBS for suspected fetal distress
1:1 support in labour
Involve a consultant obstetrician in decision making for cs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Pregnancy risks and percentages bmi >40

A

HTN in preg 10%
GDM 7%
T1 or T2 4%
CS 52%

Perinatal death 2%
Mechanical ventilation 10%
Macrosomia 20% 
SGA 19%
LGA 16%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Evidence for risking risk PET

A

LDA 100mg from 12/40, inhibits COX and TXA2 synthesis resulting in reduced platelet aggregation/vasodilation/reduced inflam response.
Reduced risk of PET 18%, stillbirth 14%, SGA16%. NNT 61 Cochrane 2019.
If at high risk, <20 weeks, NNT 19, somanz

Calcium 1g daily, reduced PTH and renin release, reduces intracellular calcium which leads to reduction in vasoconstriction. Reduces PET by 50% in high risk women and even greater if low dietary intake

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Benefits of breastfeeding

A

Maternal: weight loss, strengthens bonding, helps uterus contract post delivery and reduce PPh risk, reduces risk breast, ovarian, endometrial cancer

Neonatal: decreases sudden infant death syndrome, protects against diabetes, reduces risk obesity, reduces atopy, reduces NEC, passive immunity, lower risk of infections (otitis media, upper respiratory tract infection, UTI) acts as a mild laxative

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Priorities in PPH

A

Mechanical
Pharmacological
Surgical

Recognise
Communicate
Resuscitate
Manage
Monitoring
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

ANtiphospholipid criteria

A

Anticardiolopin IgG or IgM at high levels (IgG >40 or IgM >99th centile)

Lupus anticoagulant - positive
AntiB2glycoprotein IgM or IgG >99th

Two or more occasions, 12 weeks apart, only one positive test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Leading causes DIRECT maternal death (austrlia 2009 -2018)

A
VTE
Obstetric haemorrhage
AFE
Sepsis
Hypertensive
Suicide
25
Q

Leading causes indirect maternal death australia 2009-2018

A
CVD
Non obstetric haem
Suicide
Sepsis
Substance use
26
Q

Timing of maternal deaths

A

1/3 died while pregnant, 43% in first trimester
1/5 (22%) during labour or first 24 hours
43% postnatally

27
Q

Maternal mortality ratio

A

(direct + indirect) / number of women who gave birth, per 100 000

28
Q

WHO Sustainable developmental targets

A

By 2030
Reduce global mortality ratio to <70 per 100 000 live births
Neonatal mortality as low as 12 per 1000 live births
Universal access to sexual and reproductive health-care services including family planning, information, education

29
Q

Evidence based ways to avoid OASIS

A
  • Perineal massage in the second stage. Level 1 evidence from CSR.
  • Avoidance of instrumental delivery. Level 1 evidence from CSR.
  • Restrictive use of episiotomy. Level 1 evidence from CSR.
30
Q

Risk factors for OASIS

A

Do not allow total prediction

	Asian OR 2.27
	Nullip RR 6.97
	>4kg OR 2.27
	Shoulder dystocia 1.9
	OP position 2.44
	Prolonged 2nd stage (2-3 RR 1.47, 3-4 1.79, >4 2/02)
	Instrumental 
		Ventouse no epis 1.89
		Ventouse epi 0.57
		Forceps no epis OR 6.53
Forceps epis 1.34
31
Q

RCOG bundle for avoiding OASI

A

AN education to women
Hands on birth
Episiotomy if needed
Thorough PR exam

32
Q

Obstetric risks regional anaesthesia

Cochrane 2018

A

Instrumental delivery (not in new data since 2005)
Longer first and second stage, more likely to need synt
Maternal hypotension, fever, urinary retention
Increased CS for distress but not overall

33
Q

Vitamin D

A

Not consistently shown to improve maternal or neonatal outcomes
Universal prescribibng, 400IU, present hypocalcaemic seizures and rickets

BF infants 400IU for 1st 6/12, formaula not needed

Increases maternal and cord blood levels vit D
Does not improve maternal obstet outcomes
Does not improve infant levels at 3,6,12 months
Does not improve NNatal bone density @ 2/52
Assoc w 20% reduction childhood wheezing @ 3 years, regardless of maternal Vit D level

34
Q

2 postulates theories of hyperemesis

A

Sensitivity to HCG - more hcg associated with more vomiting, such as in multiple pregnancy or GTD, acts as thyroid stimulator and correlated with degree of biochemical thyrotoxicosis

Elevated estrogen- reduced gastric motility and emptying

35
Q

When is inpatient monitoring recommended for hyperemesis ?

A

Severe electrolyte disturbance <3.0
Significant renal creat >90
Concurrent comorbidity: T1DM, short bowel, critical meds-epilepsy/transplant patients
Malnutrition/continuing significant weight loss despite therapy
Associated conditions Eg infection, haematemesis

36
Q

Pemphigoid gestationis

A

1 in 10 000 - 60 000
Autoimmune, IgA attacking basement membrane
Seen w bullous pemphigoid, T1DM, graves, pernicious, vitiligo, RA, HLA DR3, HLA DR4

Abrupt onset, 2nd trimester, earlier each time. May recur w menstruation, COCP, preg.

Intensely pruritis Papules, plaques, target annular lesions then get vesicles, bullae, become tense, can get secondary bacterial infection.

TESTS
Biopsy - subepidermal vesicles, oedema, basal layer, , necrosis basal cells
IMMUNOFLUORESENCE - c3 complement deposition at basement membrane, IgG antibodies

Rx
MDT
Cool baths, emollients, 
Steroids, topical and systemic
Immune suppression
37
Q

PEP/PUPP

A

1 in 200
No hormonal abnormality, related to stretching skin, damage to connective tissue

Assoc with: increased wt gain, inc birth weight, primips, multiples

THIRD trimester, self limited, resolves rapidly, does not recurr. Abdominal and proximal limbs

Along striae, umbilical sparing.
NEGATIVE immunofluroesnce

38
Q

How common is perinatal anxiety and depression ?

A
Baby blues 80%, 3-5 days of birth, lasting for 10
AN anxiety/depression 10%
PN anx/dep 16%
anxiety alone 20%
Puerperal psychosis 1 in 1000 
PTSD 2-3%
39
Q

Causes of nonimmune hydrops

A
Chromosomal - T13/18
Anaemia - fetomaternal haemorrhage
Structural - CPAM, thoaracic abN
Twin to twin, tumours
Infective - toxo, syphilis, cmv
Cardiac arrythmia
40
Q

What shows evidence of haemolysis ?

A

Schistocytes
LDH >600
Bilirubin >20
REduced haptoglobin

41
Q

Differentials for thrombocytopenia

A

Pregnancy:
PET, HELLP, AFLP, DIC

Immune
ITP, HUS, antiphospholioid, TTP, aHUS, HUS

Non immune
b12 deficiency, aplastic anaemia, toxins, congenital, infection - HIV, hepatitis, H pylori

42
Q

Initial investigations for thrombocytopenia

A
FBC + reticulocyte count
Peripheral blood film
Optical platelet count
Coagulation screen
Renal and liver function tests
TFTs
Direct coombs
Antiphospholipid: Lupus, anticardiolipin, b2glycoprotein 1 antibodies
ANA 
Hep B/c/HIV
H pylori
Vit 12/folate
Immunoglobulins
43
Q

Thresholds for treating thrombocytpoemia

A

Symptomatic with active bleeding - any threshold
<20
Delivery required and <50 x10^9

44
Q

Findings + pathophy AFE

A
  1. Cardiopulmonary arrest or acute hypotension
  2. Acute Hypoxia
  3. DIC or severe haemorrhage in absence of other explain
  4. No other cause and within 30-60minutes of labour/delivery

Amniotic fluid or fetal debris breaching maternal circulation, anaphylactoid type reaction
Hypotension - peripheral vasodilatation, loss of venous return
Thrombocytopenia - debris triggering extrinsic coag pathway, consumptive coagulopathy
Bleeding - development DIC, vaginal bleeding, bleeding other sites

45
Q

Causes of decreased variability on CTG

A
Sleep trace (up to 40mins)
Early gestation age, <32 weeks
Medications: opioids, b blockers, mag, steroids
Incorrect recording speed
Chronic hypoxia
46
Q

Intraoperative placenta praevia risks:

A
Massive haemorrhage 21%
Hysterectomy 11%
ICU admission 10%
Further laparotomy 7-8%
Bladder or ureteric injury 6%
VTE  3%
Death 1 in 12 000
47
Q

USS findings spina bifida 2nd trimester

A

Anencephaly, hydrocephaly, ventriculomegaly
Abnormally shaped + open vertebrae
Dorsal ossification centres/lateral pedicles splayed apart
Lemon sign - abN size and shape fetal head, narrowing bones at frontal portion
Banana sign: cerebellum wrapped around medulla as part of Chiari malformation

48
Q

3 tests @ preconceptual counselling for lupus nephritis

A

anti Ro/La antibodies –> congenital heart block
dsDNA (ANA, complement C3/4) risk of flare
APL status - anti cardiolipin, beta 2 glycoprotein

Risk of flare approx 15-20%

49
Q

Anatomy of pudendal nerve

A

Arises from S2,3,4
Leaves pelvis via greater sciatic foramen
Re-enters and hooks around ischial spine, within lesser sciatic foramen
Passes beneath sacrospinous ligament
Branches out to form dorsal nerve of clitoris, perineal nerve, inferior rectal branches –> supplying perineum

CLOSE to ischial spine means idenitifiable and LA can be infiltrated to produce anaesthesia for perineum

50
Q

Risks of cs @ Fully compared to instrumental:

maternal AND fetal

A
Tears in incision
Haemorrhage 
Blood transfusion
Bladder trauma
ICU
Future risks: scar rupture, abnormal placentation, adhesions

Fetal: neonatal acidosis, ICH, need for resus

51
Q

Factors associated with higher rates of instrumental failure:

A

BMI >30
EFW >4
OP
Mid cavity or >1/5 head palpable abdominally

Should have CS available within 30 mins if attempting instrumental

52
Q

Episiotomy with instrumental?

A

Womens Healthcare initiative australia says all women having first vaginal birth thats assisted.

24% oasis if forceps
16% if ventouse

NNT 19 episiotimes in primips

53
Q

Forceps vs vacuum rates of complication

A
Fail RR 0.65
Cephalohaematoma RR 0.64
Retinal haemorrhage RR 0.6
Neonatal jaundice 0.79
Fewer shoulder dystocia RR 0.4

higher
OASIS 1.89
Any vag trauma 2.48
Incontinence RR 1.77

NO change in nn injury, low apgars at 5 mins, acidaemia

54
Q

USS features of CMV

A

Microcephaly
CNS
Calcification intracranial/abdominal
Hydrops, ascites, oligo/poly, hepatomegaly, pleural effusions
HyperEchogenic bowel, psuedomeconium ileus
IUGR

55
Q

Diagnosing CMV

A

1 in 300 women get infected
approx 30% transmit to babies
10% get congenital issues

may be incidental finding elevated LFTs in Mum
IgM and IgG
If IgM positive, then look at IgG, if LOW avidity then recent infection

56
Q

Main neonatal concerns CMV

A

Early mortality 5-10%
Neurological sequalae microceph, seizures (10%), chorioretinitis (10-20%0, developmental delay
SNHL (25-50%, progression expected in about half)

ASYMPTOMATIC
SNHL 5% (only 1/2 will be detected in newborn period)
Chorioretinitis 2%

57
Q

Age related probability of T21

A

Baseline population 1 in 400
Age 35 - 1 in 300
Age 40 - 1 in 100

58
Q

Other than nuchal, what other factors can improve sensitivitity of CFTS?

A

Presence of nasal bone
Tricuspid valve
Ductus venosus waveform